Factors associated with receipt of second injection of naltrexone for opioid use disorder: Secondary analysis of 5 clinical trials
{{output}}
Background and objectives: Extended-release injectable naltrexone (XR-naltrexone) is an effective relapse prevention treatment of patients with opioid use disorder (OUD), but retention remains a problem. Previous trials have eith... ...
